TiGenix
M&A/ News/ R&D/ UK & Europe
Takeda to buy stem cell specialists TiGenix for $626m
Richard Staines
European biotech, gastroenterology, M&A, Takeda, TiGenix
0 Comment
Decision follows EU regulators’ decision to back Crohn’s stem cell therapy
X
Takeda to buy stem cell specialists TiGenix for $626m
https://pharmaphorum.com/news/takeda-buy-gastro-biotech-tigenix-463m/
Market Access/ News/ News/ Pharma Market Access/ R&D
First ever ‘off the shelf’ stem cell therapy nears European approval
Richard Staines
advanced therapies, Crohn's disease, gastroenterology, Rare diseases, regulation, stem cell therapy, Takeda, TiGenix
0 Comment
Alofisel recommended for complex perianal fistulas in Crohn’s disease
X
First ever ‘off the shelf’ stem cell therapy nears European approval
https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/